Effect of Subperiosteally Implanted Polytetrafluoroethylene (PTFE) Material on Alveolar Bone in the Rat

J. Grevstad

Full text link: https://pubmed.ncbi.nlm.nih.gov/8362201/

Effect of Subperiosteally Implanted Polytetrafluoroethylene (PTFE) Material on Alveolar Bone in the Rat

1. Scientific Reference

• Study title: Effect of subperiosteally implanted polytetrafluoroethylene (PTFE) material on alveolar bone in the rat
• Author: H. J. Grevstad
• Scientific journal: Not specified in the information provided.
• Year of publication: 1993
• DOI: 10.1111/j.1600-0722.1993.tb01109.x
• PMID: 8362201

2. Scientific Background

The biological response of alveolar bone to materials placed directly against its surface is an important consideration in experimental oral surgery and biomaterial research. Beyond the macroscopic appearance of healing, cellular changes within superficial bone may provide valuable information about the local tissue response to a foreign material.

This experimental study focused on the consequences of positioning polytetrafluoroethylene (PTFE) beneath a mucoperiosteal flap and directly over maxillary alveolar bone. Rather than assessing clinical performance, the investigation examined changes at the osteocyte level using transmission electron microscopy.

By comparing bone immediately beneath the implanted PTFE with neighboring alveolar bone, the study provides insight into the spatial distribution of early cellular alterations associated with subperiosteal material placement. Its relevance is therefore primarily biological and preclinical, particularly for understanding bone–biomaterial interactions in procedures involving close contact between implanted materials and osseous surfaces.

3. Objective of the Study

The primary objective was to investigate the effect of subperiosteal PTFE implantation on osteocytes within maxillary alveolar bone in a rat model.

The researchers specifically examined whether osteocytes located in bone directly beneath the implanted material showed a different degree of cellular degeneration compared with osteocytes in adjacent bone. No additional clinical or therapeutic objectives are described in the information provided.

4. Methodology

This was a preclinical experimental animal study involving four young conventional albino rats. Mucoperiosteal flaps were elevated through sulcular incisions, after which 1 × 4 mm segments of PTFE were positioned between the maxillary bone surface and the flap tissue.

After a 14-day healing period, specimens containing the implanted material and surrounding bone were prepared for transmission electron microscopy. The samples were progressively reduced to generate 16 levels for thin-section examination.

A total of 640 osteocytes were evaluated. Two anatomical regions were distinguished: alveolar bone directly beneath the PTFE material (region 1) and adjacent alveolar bone (region 2). The analysis focused on the relative presence of intact versus degenerated osteocytes.

5. Main Results

The ultrastructural evaluation identified a marked difference in osteocyte integrity between bone directly covered by the PTFE and the neighboring region.

In region 1, located beneath the implanted material, 56% of the osteocytes exhibited distinct signs of necrocytosis. In comparison, 16% of osteocytes in the adjacent bone of region 2 demonstrated such changes.

The findings therefore indicate a substantially greater proportion of altered osteocytes in superficial alveolar bone directly associated with the subperiosteal PTFE placement.

Within the conditions of this animal experiment and at the 14-day assessment point, the findings were interpreted as evidence of partial necrosis affecting superficial alveolar bone beneath the implanted material.

The information provided contains no human clinical outcomes and does not address implant survival, bone regeneration, or longer-term tissue recovery.

6. Clinical Analysis

The main value of this study lies in its demonstration that a material positioned directly over an osseous surface may be associated with localized cellular changes within the underlying bone. The contrast between the two examined regions is particularly relevant: osteocyte alterations were considerably more frequent in the bone directly covered by PTFE than in the adjacent area.

From a biological perspective, these observations highlight the importance of evaluating bone–material interactions at the cellular level. In oral surgery and biomaterial research, apparently localized contact conditions may influence superficial bone viability, and transmission electron microscopy can reveal changes that would not necessarily be apparent from macroscopic assessment alone.

However, the clinical implications should not be overstated. Only four rats were included, and tissue evaluation was performed after 14 days. The available data do not establish whether the observed changes would subsequently resolve, persist, or progress.

Furthermore, the experiment cannot be used to infer the clinical safety or effectiveness of contemporary dental implant procedures, guided bone regeneration techniques, bone grafting protocols, or current PTFE-based devices. The findings concern a specific experimental model and should primarily be interpreted as evidence of a short-term biological response rather than as a direct basis for human treatment recommendations.

7. Clinical Applications

The study is potentially relevant to the broader biological assessment of materials positioned in close proximity to alveolar bone during oral surgical procedures. In particular, it emphasizes the need to consider superficial bone viability when evaluating the local response to a material placed between bone and mucoperiosteal tissues.

Its practical applicability remains limited by the experimental design. The available information does not evaluate dental implants, implant-supported rehabilitation, guided bone regeneration, bone grafting, or clinical outcomes in human patients. Consequently, these findings should not be directly extrapolated to contemporary implant dentistry or reconstructive protocols.

Their principal clinical relevance is therefore conceptual: they contribute to understanding how direct material–bone contact may influence local osseous cell integrity.

8. Level of Evidence, Limitations, and Transparency

This investigation is a preclinical animal experiment and therefore provides a limited level of evidence for clinical decision-making in humans. It should not be interpreted as a clinical trial or as evidence supporting a definitive therapeutic recommendation.

Important limitations can be identified from the study information provided. The experiment involved only four animals, and the biological response was assessed at a single 14-day time point. No longer-term observations are reported in the available abstract, preventing conclusions regarding subsequent healing, persistence of cellular damage, or recovery of the affected superficial bone.

In addition, translation from a rat maxillary model to human oral surgery requires substantial caution.

No information concerning funding, author conflicts of interest, or relationships with manufacturers is included in the material provided. These aspects therefore cannot be assessed.

9. Key Study Points

• Study type: Preclinical experimental animal study.
• Level of evidence: Preclinical; limited direct clinical evidence.
• Study population: Four young conventional albino rats.
• Number of patients or implants: No human patients; four experimental animals.
• PTFE segment dimensions: 1 × 4 mm.
• Observation period: 14 days.
• Assessment method: Transmission electron microscopy.
• Osteocytes evaluated: 640.
• Primary outcome assessed: Integrity versus degeneration of osteocytes in alveolar bone beneath the implanted material and in adjacent bone.
• Main result: Distinct signs of necrocytosis were identified in 56% of osteocytes beneath the PTFE compared with 16% in adjacent bone.
• Scientific conclusion: Subperiosteal PTFE placement was associated with partial superficial alveolar bone necrosis under the conditions of this rat experiment.
• Main limitations: Small animal sample, short observation period, single assessment point, and limited direct applicability to human clinical practice.

10. Scientific Impact

The study contributes experimental evidence on the cellular response of alveolar bone following subperiosteal placement of PTFE. Its distinctive contribution is the ultrastructural assessment of osteocytes combined with a regional comparison between bone directly beneath the material and neighboring alveolar bone.

The substantially different proportions of osteocytes displaying necrocytotic changes indicate that the biological effect observed in this model was concentrated primarily in the area directly associated with the implanted material.

These findings provide a basis for considering superficial bone viability when investigating interactions between biomaterials and osseous tissues. At the same time, the study leaves several questions unresolved. The available data do not establish the longer-term evolution of the affected bone or determine whether comparable responses occur in humans.

Its scientific contribution should therefore be viewed primarily as preclinical evidence identifying a localized biological phenomenon that may warrant further investigation rather than as validation or rejection of a specific clinical technique.

11. Editorial Conclusion

Grevstad’s experimental study identified a markedly higher frequency of osteocyte alterations in alveolar bone directly beneath subperiosteally implanted PTFE than in adjacent bone after 14 days. The findings provide useful ultrastructural evidence of a localized superficial bone response to material placement in this rat model. Their interpretation must nevertheless remain cautious because of the small animal sample, short observation period, and absence of human clinical data. The study is therefore most relevant as a contribution to the biological understanding of bone–biomaterial interactions.